- Investing.com
तुलना करने के लिए मीट्रिक्स | PODD | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधPODDपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 28.6x | 5.8x | −0.3x | |
PEG अनुपात | 0.48 | −0.10 | 0.00 | |
क़ीमत/बुक | 7.6x | 4.5x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 3.5x | 3.5x | 2.8x | |
अपसाइड (विश्लेषक लक्ष्य) | 8.0% | 54.5% | 67.2% | |
उचित मूल्य अपसाइड | अनलॉक करें | 8.9% | 10.1% | अनलॉक करें |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.